Circulating miR-17-5p and miR-20a: Molecular markers for gastric cancer

Molecular Medicine Reports

Volumn 5, Issue 6, 2012, Pages 1514-1520

  Wang, Mei ^a   Gu, Hongbing ^a   Wang, Sheng ^a   Qian, Hui ^a   Zhu, Wei ^a   Zhang, Ling ^a   Zhao, Chonghui ^a   Tao, Yang ^a   Xu, Wenrong ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Biomarker; Gastric cancer; microRNA; Peripheral blood; Prognosis

Indexed keywords

ANTAGOMIR; ANTINEOPLASTIC AGENT; MICRORNA; MICRORNA 17 5P; MICRORNA 20A; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTISENSE THERAPY; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RELAPSE; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STOMACH CANCER;

AGED; ANIMALS; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDES, ANTISENSE; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTORS; STOMACH NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 84860761077     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.828     Document Type: Article

References (21)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics 2002, CA Cancer J Clin 55: 74-108, 2005.
2. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
3. Fabian MR, Sonenberg N and Filipowicz W: Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351-379, 2010.
4. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006. (Pubitemid 44629897)
5. Xiao B, Guo J, Miao Y, et al: Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta 400: 97-102, 2009.
6. Ueda T, Volinia S, Okumura H, et al: Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11: 136-146, 2010.
7. Li X, Zhang Y, Ding J, Wu K and Fan D: Survival prediction of gastric cancer by a seven-microRNA signature. Gut 59: 579-585, 2010.
8. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
9. Tsujiura M, Ichikawa D, Komatsu S, et al: Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 102: 1174-1179, 2010.
10. Zhou H, Guo JM, Lou YR, et al: Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med (Berl) 88: 709-717, 2010.
11. Liu R, Zhang C, Hu Z, et al: A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer 47: 784-791, 2011.
12. Mostert B, Sieuwerts AM, Martens JW and Sleijfer S: Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients. Expert Rev Mol Diagn 11: 259-275, 2011.
13. Brase JC, Wuttig D, Kuner R and Sultmann H: Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer 9: 306, 2010.
14. Zen K and Zhang CY: Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev: Nov 9, 2010 (Epub ahead of print).
15. Ng EK, Chong WW, Jin H, et al: Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58: 1375-1381, 2009.
16. Li LM, Hu ZB, Zhou ZX, et al: Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 70: 9798-9807, 2010.
17. Zhao H, Shen J, Medico L, Wang D, Ambrosone CB and Liu S: A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 5: e13735, 2010.
18. Kosaka N, Iguchi H and Ochiya T: Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 101: 2087-2092, 2010.
19. Ferracin M, Veronese A and Negrini M: Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn 10: 297-308, 2010.
20. Rosell R, Wei J and Taron M: Circulating microRNA signatures of tumor-derived exosomes for early diagnosis of non-small cell lung cancer. Clin Lung Cancer 10: 8-9, 2009.
21. Chen C, Ridzon DA, Broomer AJ, et al: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179, 2005.